<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36399200</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1076</ISSN><JournalIssue CitedMedium="Internet"><Volume>182</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of pediatrics</Title><ISOAbbreviation>Eur J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Viremia as a predictor of absence of serious bacterial infection in children with fever without source.</ArticleTitle><Pagination><StartPage>941</StartPage><EndPage>947</EndPage><MedlinePgn>941-947</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00431-022-04690-7</ELocationID><Abstract><AbstractText Label="UNLABELLED">Most children with fever without source (FWS) require diagnostic laboratory tests to exclude a serious bacterial infection (SBI), often followed by admission and empirical antibiotics. As febrile children with a viral infection are less likely to have a SBI, identifying patients with systemic viral infection could contribute to exclude SBI. We evaluated whether the presence of virus in the blood could be used as a biomarker to rule out SBI. Children&#x2009;&lt;&#x2009;3&#xa0;years old with FWS were prospectively enrolled and had real-time (reverse-transcription) PCR performed on the blood for adenovirus, enterovirus, parechovirus, and HHV6. 20/135 patients had SBI, and in 47/135, at least one virus was detected in the blood. Viremia had a higher sensitivity and negative predictive value (90% and 96%) to rule out SBI compared to CRP (65% and 93%) and PCT (55% and 90%). The odds ratio (OR) for the presence of SBI among non-viremic patients was 5.8 (p&#x2009;=&#x2009;0.0225), compared to 5.5 for CRP&#x2009;&#x2265;&#x2009;40&#xa0;mg/l (p&#x2009;=&#x2009;0.0009) and 3.7 for PCT&#x2009;&#x2265;&#x2009;0.5&#xa0;ng/mL (0.0093). This remained significant after adjusting for CRP and PCT (OR 5.6 and 5.9, respectively; p&#x2009;=&#x2009;0.03 for both). Area under the ROC curve for CRP and PCT were 0.754 and 0.779, respectively, but increased to 0.803 and 0.832, respectively, when combined with viremia.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The presence of viremia had a better performance than commonly used biomarkers to rule-out SBI and could potentially be used in conjunction with CRP and/or PCT in the evaluation of children with FWS. Larger studies should evaluate the role of point-of-care testing of viruses by (revere-transcription) PCR in the plasma in management algorithms of children with FWS.</AbstractText><AbstractText Label="WHAT IS KNOWN" NlmCategory="BACKGROUND">&#x2022;&#xa0;Most children with FWS have a viral infection, but up to 15% have a SBI; most require laboratory tests, and many admission and empirical antibiotics. &#x2022; Children with a viral infection are less likely to have a SBI.</AbstractText><AbstractText Label="WHAT IS NEW" NlmCategory="BACKGROUND">&#x2022;&#xa0;Children with a&#xa0;systemic viral infection are less likely to have an SBI. &#x2022; Viremia is a better predictor of absence of SBI than commonly used biomarkers and could potentially be used in conjunction with CRP and/or PCT in the evaluation of children with FWS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galetto-Lacour</LastName><ForeName>Annick</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pediatric Emergencies, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordey</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Diagnostics Department, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papis</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of General Pediatrics, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mardegan</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of General Pediatrics, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luterbacher</LastName><ForeName>Fanny</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of General Pediatrics, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combescure</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Clinical Epidemiology, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacroix</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Pediatric Emergencies, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gervaix</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pediatric Emergencies, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Diagnostics Department, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posfay-Barbe</LastName><ForeName>Klara M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Division of General Pediatrics, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Unit, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L'Huillier</LastName><ForeName>Arnaud G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Diagnostics Department, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. arnaud.lhuillier@hcuge.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Pediatrics, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. arnaud.lhuillier@hcuge.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Unit, Department of Women, Child and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. arnaud.lhuillier@hcuge.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PRD 10-2015-II</GrantID><Agency>H&#xf4;pitaux Universitaires de Gen&#xe8;ve</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Pediatr</MedlineTA><NlmUniqueID>7603873</NlmUniqueID><ISSNLinking>0340-6199</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="Y">Viremia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">C-reactive protein</Keyword><Keyword MajorTopicYN="N">Negative predictive value</Keyword><Keyword MajorTopicYN="N">Predictor</Keyword><Keyword MajorTopicYN="N">Procalcitonin</Keyword><Keyword MajorTopicYN="N">Prognostic accuracy</Keyword><Keyword MajorTopicYN="N">Sensitivity</Keyword><Keyword MajorTopicYN="N">Viral systemic infection</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36399200</ArticleId><ArticleId IdType="pmc">PMC9672567</ArticleId><ArticleId IdType="doi">10.1007/s00431-022-04690-7</ArticleId><ArticleId IdType="pii">10.1007/s00431-022-04690-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Jr, Powell KR, Schriger DL. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. 1993;22:1198&#x2013;1210. doi: 10.1016/S0196-0644(05)80991-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-0644(05)80991-6</ArticleId><ArticleId IdType="pubmed">8517575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wier LM, Yu H, Owens PL, Washington R (2006) Overview of Children in the Emergency Department, 2010: Statistical Brief #157. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville (MD)</Citation></Reference><Reference><Citation>Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O'Leary ST, Okechukwu K, Woods CR Jr, Subcommittee On Febrile I (2021) Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics 148. 10.1542/peds.2021-052228</Citation><ArticleIdList><ArticleId IdType="pubmed">34281996</ArticleId></ArticleIdList></Reference><Reference><Citation>L'Huillier AG, Mardegan C, Cordey S, Luterbacher F, Papis S, Hugon F, Kaiser L, Gervaix A, Posfay-Barbe K, Galetto-Lacour A. Enterovirus, parechovirus, adenovirus and herpes virus type 6 viraemia in fever without source. Arch Dis Child. 2020;105:180&#x2013;186. doi: 10.1136/archdischild-2019-317382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2019-317382</ArticleId><ArticleId IdType="pubmed">31462437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla L, Gomez B, Pintos C, Benito J, Mintegi S. Prevalence of bacterial infection in febrile infant 61&#x2013;90 days old compared with younger infants. Pediatr Infect Dis J. 2019;38:1163&#x2013;1167. doi: 10.1097/INF.0000000000002461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002461</ArticleId><ArticleId IdType="pubmed">31568251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppermann N, Dayan PS, Levine DA, Vitale M, Tzimenatos L, Tunik MG, Saunders M, et al. A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr. 2019;173:342&#x2013;351. doi: 10.1001/jamapediatrics.2018.5501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2018.5501</ArticleId><ArticleId IdType="pmc">PMC6450281</ArticleId><ArticleId IdType="pubmed">30776077</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraff LJ. Management of infants and young children with fever without source. Pediatr Ann. 2008;37:673&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">18972849</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimine P. Risk stratification and management of the febrile young child. Emerg Med Clin North Am. 2013;31:601&#x2013;626. doi: 10.1016/j.emc.2013.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.emc.2013.05.003</ArticleId><ArticleId IdType="pubmed">23915596</ArticleId></ArticleIdList></Reference><Reference><Citation>Galetto-Lacour A, Zamora SA, Andreola B, Bressan S, Lacroix L, Da Dalt L, Gervaix A. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source. Arch Dis Child. 2010;95:968&#x2013;973. doi: 10.1136/adc.2009.176800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2009.176800</ArticleId><ArticleId IdType="pubmed">20515973</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano S, Bailey B, Gervaix A, Cousineau J, Delvin E, Girodias JB. Markers for bacterial infection in children with fever without source. Arch Dis Child. 2011;96:440&#x2013;446. doi: 10.1136/adc.2010.203760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2010.203760</ArticleId><ArticleId IdType="pubmed">21278424</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijman RG, Moll HA, Smit FJ, Gervaix A, Weerkamp F, Vergouwe Y, de Rijke YB, Oostenbrink R. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study. Pediatr Infect Dis J. 2014;33:e273&#x2013;279. doi: 10.1097/INF.0000000000000466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000466</ArticleId><ArticleId IdType="pubmed">25093971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J. 2008;27:654&#x2013;656. doi: 10.1097/INF.0b013e318168d2b4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e318168d2b4</ArticleId><ArticleId IdType="pubmed">18536624</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora R, Mahajan P. Evaluation of child with fever without source: review of literature and update. Pediatr Clin North Am. 2013;60:1049&#x2013;1062. doi: 10.1016/j.pcl.2013.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2013.06.009</ArticleId><ArticleId IdType="pubmed">24093895</ArticleId></ArticleIdList></Reference><Reference><Citation>Smitherman HF, Caviness AC, Macias CG. Retrospective review of serious bacterial infections in infants who are 0 to 36 months of age and have influenza A infection. Pediatrics. 2005;115:710&#x2013;718. doi: 10.1542/peds.2004-1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-1112</ArticleId><ArticleId IdType="pubmed">15741376</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine DA, Platt SL, Dayan PS, Macias CG, Zorc JJ, Krief W, Schor J, Bank D, Fefferman N, Shaw KN, Kuppermann N, Multicenter RSVSBISGotPEMCRCotAAoP, Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113:1728&#x2013;1734. doi: 10.1542/peds.113.6.1728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.113.6.1728</ArticleId><ArticleId IdType="pubmed">15173498</ArticleId></ArticleIdList></Reference><Reference><Citation>Krief WI, Levine DA, Platt SL, Macias CG, Dayan PS, Zorc JJ, Feffermann N, Kuppermann N, Multicenter RSVSBISGotPEMCRCotAAoP, Influenza virus infection and the risk of serious bacterial infections in young febrile infants. Pediatrics. 2009;124:30&#x2013;39. doi: 10.1542/peds.2008-2915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-2915</ArticleId><ArticleId IdType="pubmed">19564280</ArticleId></ArticleIdList></Reference><Reference><Citation>Byington CL, Enriquez FR, Hoff C, Tuohy R, Taggart EW, Hillyard DR, Carroll KC, Christenson JC. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics. 2004;113:1662&#x2013;1666. doi: 10.1542/peds.113.6.1662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.113.6.1662</ArticleId><ArticleId IdType="pubmed">15173488</ArticleId></ArticleIdList></Reference><Reference><Citation>Benito-Fernandez J, Vazquez-Ronco MA, Morteruel-Aizkuren E, Mintegui-Raso S, Sanchez-Etxaniz J, Fernandez-Landaluce A. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J. 2006;25:1153&#x2013;1157. doi: 10.1097/01.inf.0000246826.93142.b0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000246826.93142.b0</ArticleId><ArticleId IdType="pubmed">17133161</ArticleId></ArticleIdList></Reference><Reference><Citation>Colvin JM, Muenzer JT, Jaffe DM, Smason A, Deych E, Shannon WD, Arens MQ, Buller RS, Lee WM, Weinstock EJ, Weinstock GM, Storch GA. Detection of viruses in young children with fever without an apparent source. Pediatrics. 2012;130:e1455&#x2013;1462. doi: 10.1542/peds.2012-1391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-1391</ArticleId><ArticleId IdType="pmc">PMC3507256</ArticleId><ArticleId IdType="pubmed">23129086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafolie J, Labbe A, L'Honneur AS, Madhi F, Pereira B, Decobert M, Adam MN, Gouraud F, Faibis F, Arditty F, Marque-Juillet S, Guitteny MA, Lagathu G, Verdan M, Rozenberg F, Mirand A, Peigue-Lafeuille H, Henquell C, Bailly JL, Archimbaud C, Infection BED, in paediatric population study t, Assessment of blood enterovirus PCR testing in paediatric populations with fever without source, sepsis-like disease, or suspected meningitis: a prospective, multicentre, observational cohort study. Lancet Infect Dis. 2018;18:1385&#x2013;1396. doi: 10.1016/S1473-3099(18)30479-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30479-1</ArticleId><ArticleId IdType="pmc">PMC7164799</ArticleId><ArticleId IdType="pubmed">30389482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan P, Browne LR, Levine DA, Cohen DM, Gattu R, Linakis JG, Anders J, Borgialli D, Vitale M, Dayan PS, Casper TC, Ramilo O, Kuppermann N, Febrile Infant Working Group of the Pediatric Emergency Care Applied Research N (2018) Risk of bacterial coinfections in febrile infants 60 days old and younger with documented viral infections. J Pediatr 203 86&#x2013;91 e82. 10.1016/j.jpeds.2018.07.073</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094460</ArticleId><ArticleId IdType="pubmed">30195552</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004;4:620&#x2013;630. doi: 10.1016/S1473-3099(04)01146-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(04)01146-6</ArticleId><ArticleId IdType="pubmed">15451490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix L, Manzano S, Vandertuin L, Hugon F, Galetto-Lacour A, Gervaix A. Impact of the lab-score on antibiotic prescription rate in children with fever without source: a randomized controlled trial. PLoS ONE. 2014;9:e115061. doi: 10.1371/journal.pone.0115061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115061</ArticleId><ArticleId IdType="pmc">PMC4263728</ArticleId><ArticleId IdType="pubmed">25503770</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaciregui I, Hernandez U, Munoz JA, Emparanza JI, Landa JJ. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch Dis Child. 2009;94:501&#x2013;505. doi: 10.1136/adc.2008.146530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2008.146530</ArticleId><ArticleId IdType="pubmed">19158133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez AF, Cubells CL, Garc&#xed;a JG, Pou JF&#xa0;(2003) Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 22:895-903. 10.1097/01.inf.0000091360.11784.21</Citation><ArticleIdList><ArticleId IdType="pubmed">14551491</ArticleId></ArticleIdList></Reference><Reference><Citation>Subcommittee on Urinary Tract Infection SCoQI, Management, Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128:595-610. 10.1542/peds.2011-1330</Citation><ArticleIdList><ArticleId IdType="pubmed">21873693</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry AM, Lu X, Olsen SJ, Chittaganpitch M, Sawatwong P, Chantra S, Baggett HC, Erdman D. Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander. PLoS ONE. 2011;6:e17780. doi: 10.1371/journal.pone.0017780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017780</ArticleId><ArticleId IdType="pmc">PMC3066183</ArticleId><ArticleId IdType="pubmed">21479259</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton RJ, Bulkow LR, Miernyk K, DeByle C, Pruitt L, Hummel KB, Bruden D, Englund JA, Anderson LJ, Lucher L, Holman RC, Hennessy TW. Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol. 2010;82:1282&#x2013;1290. doi: 10.1002/jmv.21790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21790</ArticleId><ArticleId IdType="pmc">PMC7167028</ArticleId><ArticleId IdType="pubmed">20513097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung PW, Huang YC, Chang LY, Lin TY, Ning HC. Duration of enterovirus shedding in stool. J Microbiol Immunol Infect. 2001;34:167&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Van R, Wun CC, O'Ryan ML, Matson DO, Jackson L, Pickering LK. Outbreaks of human enteric adenovirus types 40 and 41 in Houston day care centers. J Pediatr. 1992;120:516&#x2013;521. doi: 10.1016/S0022-3476(05)82477-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(05)82477-1</ArticleId><ArticleId IdType="pubmed">1313095</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaschke AJ, Korgenski EK, Wilkes J, Presson AP, Thorell EA, Pavia AT, Knackstedt ED, Reynolds C, Schunk JE, Daly JA, Byington CL (2018) Rhinovirus in febrile infants and risk of bacterial infection. Pediatrics 141. 10.1542/peds.2017-2384</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810600</ArticleId><ArticleId IdType="pubmed">29343585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Augustine S, Narayan T, O'Riordan A, Das A, Kumar D, Luong JHT, Malhotra BD (2021) Point-of-care PCR assays for COVID-19 detection. Biosensors (Basel) 11. 10.3390/bios11050141</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8147281</ArticleId><ArticleId IdType="pubmed">34062874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen G, Marino J, Wang ZX, Beavis KG, Rodrigo J, Labog K, Westblade LF, Jin R, Love N, Ding K, Garg S, Huang A, Sickler J, Tran NK (2021) Clinical Performance of the point-of-care cobas liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study. J Clin Microbiol 59. 10.1128/JCM.02811-20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8111162</ArticleId><ArticleId IdType="pubmed">33239382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012;22:144&#x2013;155. doi: 10.1002/rmv.715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.715</ArticleId><ArticleId IdType="pmc">PMC3498727</ArticleId><ArticleId IdType="pubmed">22052666</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>